RiverVest Venture Fund III, L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-21
6:38 pm
Sale
2025-01-1613DRENEO PHARMACEUTICALS INC
RPHM
RiverVest Venture Fund III, L.P.196,198
1.550%
-57,224decrease
(-22.58%)
Filing
History
2025-01-10
11:05 am
Sale
2025-01-0713DSPRUCE BIOSCIENCES INC
SPRB
RiverVest Venture Fund III, L.P.23,460
4.200%
-23,570decrease
(-50.12%)
Filing
History
2024-02-02
12:31 pm
Sale
2024-01-1613DALLAKOS INC
ALLK
RiverVest Venture Fund III, L.P.108,159
0.200%
-4,848,743decrease
(-97.82%)
Filing
History
2023-05-30
4:52 pm
Purchase
2023-05-0813DRENEO PHARMACEUTICALS INC
RPHM
RiverVest Venture Fund III, L.P.253,422
7.530%
12,500increase
(+5.19%)
Filing
History
2023-05-30
4:48 pm
Purchase
2023-02-1613DSPRUCE BIOSCIENCES INC
SPRB
RiverVest Venture Fund III, L.P.47,030
8.600%
18,386increase
(+64.19%)
Filing
History